Molgramostim
In this article we are going to explore and analyze Molgramostim from different perspectives and in different contexts. Molgramostim is a topic that has captured the attention of people around the world, and its importance and impact are undeniable. Over the years, Molgramostim has sparked heated debates, driven significant change, and been a source of inspiration to many. In this post, we will take a deep look at Molgramostim to understand its meaning, relevance, and influence on our lives. From its origin to its evolution, Molgramostim has left an indelible mark on society, and it is essential to understand its reach in order to appreciate its true value. The objective of this article is to offer a complete and insightful overview of Molgramostim, and thus contribute to the understanding and discussion of this topic.
 | This article is missing information about indication, producer, .... (November 2017) |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| (verify) | |
Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.[1][2]
References
- ^ Quittet P, Ceballos P, Lopez E, et al. (2006). "Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients". Bone Marrow Transplant. 38 (4): 275–84. doi:10.1038/sj.bmt.1705441. PMC 2100150. PMID 16883311.
- ^ Orozco H, Arch J, Medina-Franco H, et al. (2006). "Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial". Archives of Surgery. 141 (2): 150–3, discussion 154. doi:10.1001/archsurg.141.2.150. PMID 16490891.
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |